Market Overview:
The global erythromycin ethylsuccinate market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The growth in the market can be attributed to factors such as rising prevalence of infectious diseases, increasing demand for antibiotics and growing awareness about the benefits of erythromycin ethylsuccinate. Based on type, the global erythromycin ethylsuccinate market is segmented into 0.1g and 0.25g segments.
Product Definition:
Erythromycin ethylsuccinate is a macrolide antibiotic. It is used to treat bacterial infections such as bronchitis, pneumonia, and sinusitis.
0.1g:
0.1g or 1/100th gram is a unit of weight used in metric system for measuring the strength of antibiotic drugs. It is most commonly used to measure the antibiotics erythromycin, clarithromycin, doxycycline and tetracycline.
0.25g:
0.25g or (100microL) is a metric unit used to measure the concentration of erythromycin ethylsuccinate, one of the main active ingredients in topical creams and ointments for acne treatment. It is also sold as a generic medicine under various brand names such as Erygel, Redness-Relieving Medicine, Mycelex-3, and others.
Application Insights:
The antibiotic is used for the treatment of various bacterial infections including bronchitis, urinary tract infections (UTIs), skin infections and gastrointestinal conditions. The growing prevalence of UTIs and the rising number of pharmaceutical companies developing new drugs to combat this condition are expected to drive demand over the forecast period. Erythromycin ethylsuccinate is also widely used as an anti-inflammatory drug owing to its ability to reduce pain and swelling caused by injury or disease. This property has led erythromycin ethylsuccinate manufacturers in collaborating with healthcare professionals for its effective use in surgeries as well as during times when other treatments have failed or patients have become resistant towards other antibiotics.
Regional Analysis:
North America was the largest regional market in 2017 owing to high consumption of erythromycin ethylsuccinate in the region. The U.S., which is a major consumer, accounted for over 80% of North America market share that year on account of higher usage rates and rising prevalence of infectious diseases such as tuberculosis, syphilis, and respiratory infections caused by bacteria such as SARS-CoV (Severe Acute Respiratory Syndrome - Coronavirus).
Asia Pacific is expected to be the fastest-growing regional market at a CAGR 5.4% from 2018 to 2030 due to increasing healthcare spending by governments along with growing awareness about antibiotic resistance among patients resulting in increased demand for effective alternative therapies for bacterial infections. In addition, favorable reimbursement policies pertaining to drug costs are anticipated to further fuel growth during the forecast period.
Growth Factors:
- Increasing prevalence of bacterial infections: The increasing prevalence of bacterial infections is one of the key growth drivers for the erythromycin ethylsuccinate market. This is because erythromycin ethylsuccinate is an effective antibiotic against a wide range of bacteria.
- Rising demand for generics: The rising demand for generics due to their lower cost as compared to branded drugs is another key growth driver for the erythromycin ethylsuccinate market.
- Growing awareness about antibiotics: There has been a growing awareness about antibiotics in recent years, which has led to an increase in their use. This is driving the growth of the erythromycin ethylsuccinate market.
- Technological advancements in drug delivery systems: The technological advancements in drug delivery systems are helping to improve the efficacy and safety profile of antibiotics such as erythromycin ethylsuccinate, thereby driving its uptake and growth prospects globally .
Scope Of The Report
Report Attributes
Report Details
Report Title
Erythromycin Ethylsuccinate Market Research Report
By Type
0.1g, 0.25g
By Application
Anti-Bacterial Agents, Enzyme Inhibitors, Protein Synthesis Inhibitors, Gastrointestinal Agents
By Companies
Chemenu Inc., Acorn PharmaTech,LLC, BLD Pharm, Boc Sciences, Bide Pharmatech Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Erythromycin Ethylsuccinate Market Report Segments:
The global Erythromycin Ethylsuccinate market is segmented on the basis of:
Types
0.1g, 0.25g
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Anti-Bacterial Agents, Enzyme Inhibitors, Protein Synthesis Inhibitors, Gastrointestinal Agents
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Chemenu Inc.
- Acorn PharmaTech,LLC
- BLD Pharm
- Boc Sciences
- Bide Pharmatech Ltd.
Highlights of The Erythromycin Ethylsuccinate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 0.1g
- 0.25g
- By Application:
- Anti-Bacterial Agents
- Enzyme Inhibitors
- Protein Synthesis Inhibitors
- Gastrointestinal Agents
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Erythromycin Ethylsuccinate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Erythromycin ethylsuccinate is a medication used to treat bacterial infections. It works by killing the bacteria that is causing the infection.
Some of the major players in the erythromycin ethylsuccinate market are Chemenu Inc., Acorn PharmaTech,LLC, BLD Pharm, Boc Sciences, Bide Pharmatech Ltd..
The erythromycin ethylsuccinate market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Erythromycin Ethylsuccinate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Erythromycin Ethylsuccinate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Erythromycin Ethylsuccinate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Erythromycin Ethylsuccinate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Erythromycin Ethylsuccinate Market Size & Forecast, 2018-2028
4.5.1 Erythromycin Ethylsuccinate Market Size and Y-o-Y Growth
4.5.2 Erythromycin Ethylsuccinate Market Absolute $ Opportunity
Chapter 5 Global Erythromycin Ethylsuccinate Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Erythromycin Ethylsuccinate Market Size Forecast by Type
5.2.1 0.1g
5.2.2 0.25g
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Erythromycin Ethylsuccinate Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Erythromycin Ethylsuccinate Market Size Forecast by Applications
6.2.1 Anti-Bacterial Agents
6.2.2 Enzyme Inhibitors
6.2.3 Protein Synthesis Inhibitors
6.2.4 Gastrointestinal Agents
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Erythromycin Ethylsuccinate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Erythromycin Ethylsuccinate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Erythromycin Ethylsuccinate Analysis and Forecast
9.1 Introduction
9.2 North America Erythromycin Ethylsuccinate Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Erythromycin Ethylsuccinate Market Size Forecast by Type
9.6.1 0.1g
9.6.2 0.25g
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Erythromycin Ethylsuccinate Market Size Forecast by Applications
9.10.1 Anti-Bacterial Agents
9.10.2 Enzyme Inhibitors
9.10.3 Protein Synthesis Inhibitors
9.10.4 Gastrointestinal Agents
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Erythromycin Ethylsuccinate Analysis and Forecast
10.1 Introduction
10.2 Europe Erythromycin Ethylsuccinate Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Erythromycin Ethylsuccinate Market Size Forecast by Type
10.6.1 0.1g
10.6.2 0.25g
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Erythromycin Ethylsuccinate Market Size Forecast by Applications
10.10.1 Anti-Bacterial Agents
10.10.2 Enzyme Inhibitors
10.10.3 Protein Synthesis Inhibitors
10.10.4 Gastrointestinal Agents
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Erythromycin Ethylsuccinate Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Erythromycin Ethylsuccinate Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Erythromycin Ethylsuccinate Market Size Forecast by Type
11.6.1 0.1g
11.6.2 0.25g
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Erythromycin Ethylsuccinate Market Size Forecast by Applications
11.10.1 Anti-Bacterial Agents
11.10.2 Enzyme Inhibitors
11.10.3 Protein Synthesis Inhibitors
11.10.4 Gastrointestinal Agents
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Erythromycin Ethylsuccinate Analysis and Forecast
12.1 Introduction
12.2 Latin America Erythromycin Ethylsuccinate Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Erythromycin Ethylsuccinate Market Size Forecast by Type
12.6.1 0.1g
12.6.2 0.25g
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Erythromycin Ethylsuccinate Market Size Forecast by Applications
12.10.1 Anti-Bacterial Agents
12.10.2 Enzyme Inhibitors
12.10.3 Protein Synthesis Inhibitors
12.10.4 Gastrointestinal Agents
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Erythromycin Ethylsuccinate Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Erythromycin Ethylsuccinate Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Erythromycin Ethylsuccinate Market Size Forecast by Type
13.6.1 0.1g
13.6.2 0.25g
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Erythromycin Ethylsuccinate Market Size Forecast by Applications
13.10.1 Anti-Bacterial Agents
13.10.2 Enzyme Inhibitors
13.10.3 Protein Synthesis Inhibitors
13.10.4 Gastrointestinal Agents
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Erythromycin Ethylsuccinate Market: Competitive Dashboard
14.2 Global Erythromycin Ethylsuccinate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Chemenu Inc.
14.3.2 Acorn PharmaTech,LLC
14.3.3 BLD Pharm
14.3.4 Boc Sciences
14.3.5 Bide Pharmatech Ltd.
